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Abstract
Background: The objectives of this study were to determine the capacity of BED incidence testing to a) estimate the effect
of a HIV prevention intervention and b) provide adequate statistical power, when used among young people from sub-
Saharan African settings with high HIV incidence rates.
Methods: Firstly, after having elaborated plausible scenarios based on empirical data and the characteristics of the BED HIV-
1 Capture EIA (BED) assay, we conducted statistical calculations to determine the BED theoretical power and HIV incidence
rate ratio (IRR) associated with an intervention when using BED incidence testing. Secondly, we simulated a cross-sectional
study conducted in a population among whom an HIV intervention was rolled out. Simulated data were analyzed using a
log-linear Poisson model to recalculate the IRR and its confidence interval, and estimate the BED practical power.
Calculations were conducted with and without corrections for misclassifications.
Results: Calculations showed that BED incidence testing can yield a BED theoretical power of 75% or more of the power
that can be obtained in a classical cohort study conducted over a duration equal to the BED window period. Statistical
analyses using simulated populations showed that the effect of a prevention intervention can be estimated with precision
using classical statistical analysis of BED incidence testing data, even with an imprecise knowledge of the characteristics of
the BED assay. The BED practical power was lower but of the same magnitude as the BED theoretical power.
Conclusions: BED incidence testing can be applied to reasonably small samples to achieve good statistical power when
used among young people to estimate IRR.
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Introduction
Since the first detuned enzyme immunoassay to detect recent
HIV seroconversion was described in 1998 [1], there has been
great interest in the application of laboratory methods to measure
HIV incidence rates from cross-sectional samples [2]. Currently,
the most widely used incidence assay is the BED HIV-1 Capture
EIA (BED) assay [3]. HIV incidence estimation is increasingly
being incorporated into HIV/AIDS surveillance activities in both
resource-rich and developing countries [4]. However, in 2005, the
UNAIDS Reference Group on Estimates, Modeling and Projec-
tions issued a cautionary statement about using BED to estimate
HIV incidence rates and called for the development of additional
laboratory and modeling methodologies [5].
The ability to reliably measure HIV incidence rate ratios (IRR)
using cross-sectional data has vast public health importance in
HIV surveillance and in prevention studies. In HIV surveillance, it
will facilitate the identification of high risk groups. In HIV
prevention studies, it will allow for the assessment of the roll-out of
current interventions, such as male circumcision, or future
interventions, such as microbicides and antiretroviral treatment
as prevention. Reliable measures of HIV incidence rates from
cross-sectional studies would reduce the need to recruit and
maintain large and costly longitudinal cohorts. However, two of
the current challenges in using HIV incidence assays to
characterize HIV incidence rates are a) knowledge of the BED
window period (i.e. time between first infection and when the test
can reliably detect that infection) and b) misclassifications. The
main source of misclassifications is the number of HIV-infected
persons falsely identified as recent seroconverters, which depends
on the proportion of HIV-positive participants whose infection
duration exceeds the BED window period.
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To reduce the sample size needed to achieve adequate statistical
power, it would make sense to use BED incidence testing among
young people because they constitute a group with a) a high HIV
incidence rate and b) low HIV prevalence, since initiation of
sexual activity is relatively recent.
The objectives of this study were to determine the capacity of BED
incidence testing to a) estimate the effect of a prevention intervention
and b) provide adequate statistical power, when used among young
people from sub-Saharan African settings with high HIV incidence
rates. Numerical values were obtained from published data.
Methods
The details of the following calculations are provided in the
Text S1, in which some computations were performed using a
symbolic calculator [6].
A theoretical estimations of the effect and of the power
We considered a population of young people at time t = 0, aged
a1 to a2, from an area where HIV is predominantly transmitted
heterosexually. We called T the maximum duration from their
onset of sexual activity, which occurred at age a1, so that T= a2-a1.
We supposed that the age distribution was uniform. This
population was divided into a control group of size N and an
intervention group of size N/m. The intervention was delivered at
some time V years before t = 0, independently of HIV status. We
supposed that all participants were HIV-negative at age a1, and
that they were only tested for HIV after the end of the
intervention. We assumed that HIV testing allowed us to a)
perfectly detect HIV-positive and HIV-negative individuals, and b)
imperfectly evaluate those having seroconverted during the BED
window period (W). We called ‘‘tested recent seroconverters’’ these
latter individuals, in contrast with those HIV-positive and long-
term seroconverters. Misclassifications were due to participants
who were falsely identified as recent seroconverters and those
falsely identified as long-term seroconverters. The HIV incidence
rate (i) was reduced by the effect (x) of the intervention, which was
the IRR between the two groups. Because of the usually low value
of the product of i by T, we approximated the probability of HIV
infection during any duration lower than T by the product of the
HIV incidence rate by this duration.
We adopted the terminology introduced by McDougal et al. [7],
who considered three time intervals. The first interval was before
HIV testing and equal in duration to the BED window period W.
The second interval was immediately before the first interval and
equal in duration to W. The third interval was the period before the
first and the second intervals. The specificities associated with the
second and third intervals are called the short-term (r1), and the
long-term (r2) specificities. The sensitivity is noted Se. To simplify
calculations, we considered that T was at least twice as long as W,
which is the case in practice. We assumed that all the parameters
were independent, and thus constant with time and age. In
particular, we did not assume a) any relationship between the
sensitivity and the specificities, b) any relationship between age and
the sensitivity and the specificities, as it has been verified for the long-
term specificity [8]. Any relationship between the sensitivity and the
specificities can be taken into account when using numerical values.
Under these hypotheses, the mean number of those tested
recent seroconverters (Ntr) in the intervention group was given by
the following formula:
(Ntr)intervention~
iNW
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In these last formulae, a, b and c are fractions and depend on the
duration of the intervention (V). They are given for V#T by
V= aW+bW+c(T-2W), and are equal to one for V$T.
The number of individuals tested recent seroconverters in the
control group was obtained from Formula 1 by replacing x by one.
The estimated effect of the intervention (x^) was calculated using
the following formula:
x^~m 1z
B
A
 
Ntrintervention
Ntrcontrol
{
B
A
ð2Þ
As shown in the Text S1, the estimated effect calculated using
Formula 2 is the maximum likelihood estimation of the effect.
The Text S1indicates the mathematical expression of the
asymptotic (i.e. when N is large) 95% confidence interval (CI) of x^.
The case of an intervention being delivered before or at the
onset of sexual activity is discussed in section 5 of the Text S1. In
this instance, the estimation of the intervention effect was equal to
the ratio of the number of individuals tested recent seroconverters
in the study groups, and did not depend on the characteristics of
the BED incidence assay. We defined the BED theoretical power
as the power obtained by statistical calculations. It appears that
this BED theoretical power, and thus the calculation of the
confidence interval, still depends on these characteristics.
In the Text S1, we also considered the case where the inferior
limit of the age range was higher than the age at onset of sexual
activity.
To avoid the hypotheses underlying the use of the delta method,
and to circumvent the assumption that N is large, we ran
simulations to compute the estimated effect of the intervention in
function of N, m, i, W, T, V, r1, r2 and Se. We proceeded as
follows: The distribution (D) of 10,000 values of the intervention
effect was obtained by sampling the number of individuals tested
recent seroconverters in each group from a binomial law,
characterized by a number of trials equal to N (for the control
group) or N/m (for the intervention group) and a probability equal
to (Ntr)control=N (for the control group) or m(Ntr)intervention=N (for
the intervention group). Ntr was calculated for each group as
described above. The effect was calculated using Formula 2. In
addition, the 0.025 to 0.975 percentile interval (D) of the effect
distribution around a nominal value of one was obtained by
generating another set of 10,000 values. The statistical power,
which is called here the ‘‘BED theoretical power’’, was given by
the proportion of values of D outside the interval D.
This process was repeated by replacing the sensitivity and the
specificities with one, to obtain the ‘‘cohort power’’, which is the
statistical power in the case of a classical cohort study. In such
study, individuals, who are HIV-negative at recruitment, are
followed-up for a duration of time equal to the BED window
HIV Incidence Tests to Evaluate HIV Intervention
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period and tested for HIV at the end of that duration, assuming no
loss to follow-up. As shown in the Text S1, in some cases, the BED
theoretical power can be slightly higher than the cohort power.
B Practical estimation of the effect and of the BED power
In practice, the BED theoretical power estimation detailed
above is not usable because empirical studies give individual data.
Independently of the previous section, we examined how to
estimate HIV IRR from empirical data using the following
method: We considered an individual j aged gj years-old and
belonging to the intervention group. We considered that the
duration of the intervention Vj varied between individuals. We
defined Tj = gj-a1 and assumed that the intervention was delivered
to that individual for Vj years, independently of his/her HIV
status. We first calculated the theoretical probability of being
tested recent seroconverter, for an HIV-positive individual having
initiated sexual activity Tj years ago, with Tj lower than a given
maximum value Tmax. Secondly, we simulated random samples of
individuals belonging to the intervention and control groups, using
these probabilities. These samples corresponded to what could be
obtained when conducting a cross-sectional study. Lastly, we
analyzed the simulated populations with classical statistical
methods to estimate the value of the intervention effect, which
was then used to simulate the data and assess the statistical power,
called the ‘‘BED practical power’’ in this study. In this section, we
use the same notations as in the previous paragraph.
Probabilities to be HIV positive and to be tested recent
seroconverter. For an individual from the intervention group,
the probability to be HIV-positive was given by the following
formula:
Pz~iW(AA’xzBB’) ð3Þ
The probability of being tested recent seroconverter when HIV-
positive was given by the following formula:
PTRzj ~
A’xzB’
AA’xzBB’
ð4Þ
In these formulae, A9 and B9 were calculated for five cases,
depending on the relative values of T, W and V, and were
independent of the HIV incidence rate. These cases are described
in the Text S1. In the case of T$2W, we obtained:
A’~aSezb(1{r1)zc(1{r2)
(T{2W)
W
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In each of the five cases, the values of AA9 and BB9 were obtained
from A9 and B9 by replacing the specificities by zero and the
sensitivity by one. For individuals in the control group, the
probability to be HIV-positive and the probability to be tested
recent seroconverter when HIV-positive were obtained by
replacing x by one in Formulae 3 and 4.
Simulation of samples. We simulated an intervention group
and a control group of the same size (N). The duration T since
sexual debut was sampled from a uniform distribution between
zero and the maximum Tmax. For individuals from the
intervention group, the time V since the beginning of the
intervention was sampled from a uniform distribution between a
minimum (Vmin) and a maximum (Vmax). HIV status and, for
those HIV-positive, results of the BED incidence testing (tested
recent seroconverter or not) were randomly allocated according to
Formulae 3 and 4. Each individual was then characterized by the
three following variables: T, HIV status, and tested recent
seroconverter (Yes or No) for those HIV-positive. In addition,
the following general variables were used: N, i, x, W, Tmax, Vmin,
Vmax, r1, r2 and V. This simulation process was repeated 10,000
times.
Estimation of the intervention effect and of the BED
practical power. We recalculated the effect of the intervention,
computed as an HIV IRR, from the simulated samples. We used a
Poisson log-linear model which is equivalent to the exponential
model [9,10,11], assuming that the instantaneous incidence is
constant over time. This model was applied to all individuals from
each simulation. This model required the knowledge of the
probability k1 of being infected with HIV within the window
period W for individuals tested HIV-positive and recent
seroconverters, as well as the probability k2 of being infected
with HIV within W for those tested HIV-positive and tested long-
term seroconverters. As described in the Text S1, for intervention
group participants, calculations gave the following expressions for
k1 and k2.
k1~Se
C’xzD’
A’xzB’
and k2~(1{Se)
C’xzD’
(AA’{A’)xzBB’{B’
C9 and D9 were obtained from A9 and B9 by replacing the
specificities and the sensitivity by one. AA9 and BB9 were obtained
from A9 and B9 by replacing the specificities by zero and the
sensitivity by one. The corresponding values of k1 and k2 for
participants in the control group were obtained by replacing x by
one. The values of k1 and k2 did not depend on the HIV incidence
rate. To correct for an effect due to misclassifications (false recent
seroconverters and false long-term seroconverters), weights of k1
were used for individuals tested recent seroconverters, weights of
k2 were used for those tested long-term seroconverter, and weights
of one were used for those tested HIV-negative. Because the
weights depended on the effect of the intervention, Poisson log-
linear regressions were repeated until a stable value for the
intervention effect was reached. This process was initiated with a
value of 0.5 for the first calculation of the weights. The duration of
HIV exposure was introduced as an offset in the model. Each
individual who remained HIV-negative was denoted as having a
duration of exposure equal to the minimum value between W and
T. Each individual who became HIV-positive was denoted as
having a duration of exposure equal to half the minimum value
between W and T. The estimated effect was calculated as the
median effect generated from the 10,000 simulated samples. The
statistical power needed to obtain a significant value for the HIV
IRR was calculated as the fraction of the samples with a p-value
lower than 0.05.
C Numerical values
The conventional cut-off value for the BED assay is 0.80,
corresponding to a BED window period W of about six months.
However, an empirical study has shown that higher cut-off
values of up to 1.89, corresponding to a W of about 15 months,
can be used among young people [12]. We used values of W of
six, nine, 12 and 15 months in this study. There are several
approaches to establish the relationship between the cut-off value
and W. One consists in considering a cohort of HIV-negative
individuals followed up for a period of 2W, and then choosing a
cut-off value such that, at the end of the 2W-period, the number
HIV Incidence Tests to Evaluate HIV Intervention
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of those who became HIV-positive during the second W period
is equal to the number of those tested recent seroconverters. This
is the method used in the publication quoted above, and what
was applied in the present study. This method implies that the
sensitivity is equal to the short-term specificity. Using other
relationships between the cut-off value and W leads to other
equations, such as sensitivity equals short-term specificity plus
one minus long-term specificity [13]. The two methods give very
close results because one minus the long-term specificity is in the
range of 0.05 to 0.08.
Using empirical data from a previous study [12], we chose to
use a linear relationship between the long-term specificity and W
(in months), r2 = 1–0.0071W, and a constant value for the
sensitivity, Se = 0.87. However, we also varied these numbers
across a wide range of possible numerical values.
We selected baseline values for HIV incidence rates of 2.1% per
year among young men and 5% per-year among young women,
which are typical HIV incidence rates in high HIV incidence
settings of sub-Saharan Africa. We chose an intervention reducing
the HIV incidence rate by 60%, corresponding to an effect (IRR)
of 0.4. Among men, these baseline data correspond to what was
observed during the male circumcision trial conducted in Orange
Farm (South Africa) [14].
D Generation of results
BED theoretical power. We computed the theoretical
power of the BED assay (the BED theoretical power) using the
baseline scenarios. This BED theoretical power was also calculated
as a fraction of the power obtained in a cohort study (called the
cohort power). We assessed the effect of the baseline values on the
BED theoretical power by varying a) the sample size of each
group, b) the BED incidence assay window period W, c) the
duration since sexual debut, d) the HIV incidence rate in the
control group, e) the specificities and the sensitivity of the assay, f)
the duration of the intervention and g) the effect of the
intervention on HIV incidence rates.
Practical estimations. To assess the possibility of
estimating the intervention effect, and to calculate the BED
practical power when using a Poisson regression log-linear model
on empirical data, we first simulated sets of control and
intervention groups using the numerical values of the baseline
scenarios. We then analyzed the simulated samples using the
numerical values of the baseline scenario for the BED incidence
assay characteristics (specificities, sensitivity and window period).
This represented a theoretical situation where the characteristics
of the BED assay are perfectly known, which is not the case in
reality. To analyze the effect of these uncertainties, we analyzed
the simulated population with characteristics for the assay
different from those used to generate the samples. We also
assessed the effect of not including offsets or weights when
estimating the intervention effect and calculating the BED
practical power. Not including weights corresponds to not
correcting the data for misclassifications.
Programming. The program was written in R [15], and is
available upon request from the corresponding author. In
addition, we created a spreadsheet to calculate by simulation the
BED theoretical power to detect an expected effect of an
intervention when the following parameters are known: age at
onset of sexual activity, age range, HIV incidence rate in the
control group, expected effect of the intervention, duration of the
intervention, and lastly the window period, sensitivity, and
specificities of the BED assay. This spreadsheet is available upon
request from the corresponding author.
E Empirical example
We reanalysed the BED results obtained from data collected at
the last follow-up visit of the Orange Farm male circumcision trial
(ANRS-1265) [12,14]. The research protocol for this trial was
reviewed and approved by the University of the Witwatersrand
Human Research Ethics Committee (Medical) on February 22nd,
2002 (protocol study no. M020104). In this trial, male participants,
aged 18 to 24, were recruited from the general population of the
township of Orange Farm (South Africa) and followed up for 21
months. The recruitment, randomization between intervention
(male circumcision) and control groups, and follow-up were
conducted independently of the participants HIV status. Among
the 3274 participants recruited, 2949 were tested for HIV at the last
follow-up visit (21-month visit). Among them, 2752 remained HIV-
negative, 125 were HIV-positive at recruitment and 72 serocon-
verted during follow-up. Among the 197 HIV-positive samples at
the last follow-up visit, 195 BED results were obtained. This dataset
was analyzed using a mean reported age at first sexual intercourse of
16.7 years, assuming a) a constant HIV incidence rate and b) a
linear increase of the HIV incidence rate from a value of zero at age
16.7. The intention-to-treat effect of male circumcision was
calculated for various cut-off values and various values for the
sensitivity and specificities indicated above. The estimated effects
were qualitatively compared with the value obtained from classical
survival analysis, which was 0.40 (95% CI: 0.24–0.68).
Lastly, we conducted a sensitivity analysis by varying the
sensitivity and the specificities, in order to evaluate the impact of
these changes on the estimated effect of the intervention.
Results
BED theoretical power
The baseline scenarios for young men (scenario 1) and young
women (scenario 2) are detailed in Table 1. As shown in this table,
the BED theoretical power, obtained by simulations to detect a
significant effect, increases with increasing HIV incidence rate
(scenario 2), BED window period W (scenarios 3, 4 and 5), sample
size (scenario 6), and duration of the intervention (scenario 10).
The power decreases with increasing time from sexual debut
(scenarios 7 and 8), with decreasing intervention effect (scenario 9)
and with decreasing specificities and sensitivity of the assay
(scenarios 11 and 12). This table shows that the ratio between the
BED theoretical power and the cohort power is always high, equal
to 75% or more. Figure 1 shows the variation of the BED
theoretical power with the ratio of the HIV incidence rate to HIV
prevalence for the baseline scenarios. This power increases for
ratios varying from 0.1 to 0.4, and then stabilizes.
To obtain a power of 80%, with a BED window period of one
year and with the other values being those of scenario 1, the
sample size of each group should to be 670 for young women,
assuming an HIV incidence rate of 5% per year, and 1,650 for
young men, assuming an HIV incidence rate of 2.1% per year.
Practical estimations
Table 2 presents the results obtained when estimating the
intervention effect on simulated data using a log-linear Poisson
model. It shows that this estimation is always relatively close to the
real value. It also indicates that the cases where estimations are the
poorest are when a) the characteristics of the assay are not known
with precision (simulations 6 and 9) and b) the Poisson model is not
weighted (simulations 3 to 5).
In all other cases, this estimation ranged from 0.37 to 0.39 for a
real value of 0.40. Table 2 also shows that the BED practical power
was about 3/4 of the BED theoretical power for men and was about
HIV Incidence Tests to Evaluate HIV Intervention
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e21149
Table 1. BED theoretical power needed to obtain a statistically significant HIV incidence rate ratio among young people when
using BED incidence testing; results were obtained by simulations.
Scenario 1b 2c 3 4 5 6 7 8 9 10 11 12
Data
Sample size in each group 1500 1500 1500 1500 1500 2000 1500 1500 1500 1500 1500 1500
BED Incidence assay
window period (months)
6 6 9 12 15 6 6 6 6 6 6 6
Duration from sexual
debut (years)
6 6 6 6 6 6 9 12 6 6 6 6
HIV incidence rate in the
control group (% per year)
2.1 5.0 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1
Short-term specificity 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.80 0.75
Long-term specificity 0.96 0.96 0.94 0.91 0.89 0.96 0.96 0.96 0.96 0.96 0.90 0.85
Sensitivity 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.87 0.80 0.75
Duration of the
intervention (years)
2 2 2 2 2 2 2 2 2 4 2 2
Effect of the interventiona 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4
Results
BED theoretical power 0.62 0.91 0.73 0.77 0.85 0.72 0.53 0.50 0.45 0.70 0.54 0.53
Cohort power 0.66 0.93 0.80 0.88 0.94 0.75 0.67 0.67 0.47 0.66 0.65 0.66
BED theoretical power/
Cohort power (%)
94 97 91 87 90 95 80 75 95 1.07 83 81
Incidence rate/Prevalence in
the control group (per year)
0.33 0.33 0.33 0.33 0.33 0.33 0.22 0.17 0.33 0.33 0.33 0.33
aFactor by which the incidence rate is multiplied in the intervention group in comparison with the control group.
bBaseline scenario for young men.
cBaseline scenario for young women.
doi:10.1371/journal.pone.0021149.t001
Figure 1. BED theoretical power as a function of the HIV incidence rate to HIV prevalence ratio. Results were obtained by simulations.
The figure represents the BED theoretical power among young men and women as a function of the HIV incidence rate to HIV prevalence ratio for
the baseline scenarios.
doi:10.1371/journal.pone.0021149.g001
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the same as the BED theoretical power for women. The average
weights k1 ranged from 0.44 to 0.83 among the intervention group
and from 0.61 to 0.93 among the control group.
To obtain a BED practical power equal to the cohort power
indicated in Table 1 for the baseline scenarios (0.66 and 0.93), the
sample size of each group had to be increased from 1,500 to 2,100
for men, and from 1,500 to 1,650 for women.
To obtain a BED practical power of 0.80 for the baseline
scenarios, with a BED window period W of one year and
corresponding values for the specificities and sensitivity, the sample
size of each group was calculated to be 1,540 for men and 600 for
women.
The calculations in the Text S1demonstrate that, in order to
keep the weights k1, which correct for misclassifications,
reasonably close to 1 (i.e., between 0.5 and 1), a) the time period
from the onset of sexual debut to the upper age limit should be
lower than 10 to 11 years and b) in the control group, the HIV
incidence rate to HIV prevalence ratio should be higher than 0.09
to 0.10 year21.
We generated datasets using the baseline scenarios but with a
HIV incidence rate linearly increasing from age a1 to a2. The slope
was selected in order to obtain the same number of HIV-positive
cases in the control group when the HIV incidence rate was
constant. We then analysed these datasets assuming a) a HIV
incidence rate constant with age and b) a HIV incidence rate
linearly increasing, as in the simulated data. In the first case, we
obtained an effect of 0.33 (95% CI: 0.13–0.83) and 0.31 (95%CI:
0.17–0.57). In the second case, the values were 0.39 (95%CI:
0.18–0.85) and 0.37 (95%CI: 0.22–0.62).
Empirical example
The results are presented in Table 3. The values obtained for
the effect of male circumcision on the HIV incidence rate, when
assuming that this rate is constant, were in reasonably good
Table 2. HIV incidence rate ratio and BED practical power when using log-linear Poisson regression to analyze simulated samples
of young people.
Simulation number 1 2 3 4 5 6 7 8 9 10 11
Scenario # used to
generate the sample
1 1 1 1 1 1 1 2 2 2 12
Values used to analyze the sample
Use of offset Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes
Weights for tested recenta k1 k1 1 k1 1 k1 k1 k1 k1 k1 k1
Weights for tested long-termb k2 k2 k2 0 0 k2 k2 k2 k2 k2 k2
BED Incidence assay
window period (months)
6 6 6 6 6 6 8 6 6 8 6
Short-term specificity 0.87 0.87 0.87 0.87 NA 0.80 0.87 0.87 0.80 0.87 0.75
Long-term specificity 0.96 0.96 0.96 0.96 NA 0.90 0.96 0.96 0.90 0.96 0.85
Sensitivity 0.87 0.87 0.87 0.87 NA 0.80 0.87 0.87 0.80 0.87 0.75
Results
Number of tested recent
Intervention 8 8 8 8 8 8 8 19 19 19 13
Control 17 17 17 17 17 17 17 42 42 41 24
Effect of the interventionc 0.39 0.39 0.44 0.39 0.44 0.35 0.40 0.37 0.34 0.39 0.38
95% CI: inferior limit 0.15 0.15 0.20 0.14 0.19 0.12 0.17 0.20 0.17 0.22 0.15
95% CI: superior limit 1.01 1.00 0.97 1.09 1.02 1.01 0.98 0.69 0.67 0.69 1.00
HIV incidence rate (% per year) 2.2 2.9 1.9 2.5 2.0 1.9 5.8 5.1 4.9 2.2
95% CI: inferior limit 1.3 NC 1.8 1.1 1.6 1.1 1.2 4.2 3.6 3.6 1.3
95% CI: superior limit 3.7 4.5 3.3 4.1 3.4 3.0 8.1 7.3 6.7 3.7
BED practical power 0.49 0.50 0.52 0.41 0.47 0.49 0.52 0.92 0.93 0.93 0.50
Average weights for tested recenta:
Intervention 0.66 0.66 1 0.65 1 0.46 0.72 0.65 0.46 0.72 0.33
Control 0.75 0.75 1 0.75 1 0.58 0.79 0.75 0.58 0.79 0.46
Average weights for tested long-termb:
Intervention 0.012 0.013 0.014 0 0 0.021 0.020 0.013 0.021 0.021 0.029
Control 0.024 0.024 0.024 0 0 0.039 0.036 0.025 0.039 0.038 0.052
BED practical/BED theoretical
powerd (%)
0.79 0.81 0.84 0.66 0.76 0.79 0.84 1.01 1.02 1.02 0.94
NC= not calculable NA=Not applicable CI = confidence interval.
a bWeights k1 and k2 introduced in the Poisson log-linear model for each group
a among HIV-positive tested recent seroconverters and b among HIV-positive tested
long-term seroconverters.
cFactor by which the incidence rate is multiplied in the intervention group in comparison with the control group.
dThe BED theoretical power was obtained from Table 1 (0.62 for simulations 1 thru 7, 0.91 for simulations 8 thru 10, and 0.53 for simulation 11).
doi:10.1371/journal.pone.0021149.t002
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agreement with the values obtained from classical survival analysis.
The hypothesis of a constant HIV incidence rate is justified by the
linear variation of HIV prevalence with age ranging from 18 to 26,
as shown in Figure 2. HIV prevalence was zero for the age range
15 to 17. As shown in Table 3, the effect was statistically significant
for all of the four BED cut-off values.
When we did not correct for the sensitivity (i.e. Se = 1), we
obtained the following values for the effect of the intervention:
0.43, 0.38, 0.35 and 0.38, which are very close to the values
reported in Table 3.
When we did not correct for the short-term specificity (i.e.
r1 = 1), we obtained the values 0.41, 0.35, 0.33 and 0.39, which
are also very close to the values reported in Table 3.
When we did not correct for the long-term specificity (i.e.
r2 = 1), we obtained the values 0.52, 0.49, 0.48 and 0.50, which
are, in this case, underestimations of the effect of the intervention.
Figure 2. HIV prevalence by age obtained among uncircumcised men of the Orange Farm Community. This figure represents the HIV
prevalence by age, with 95% confidence intervals, obtained among a random sample of uncircumcised men of the Orange Farm (South Africa)
Community in 2007. A linear regression line has been added to the data.
doi:10.1371/journal.pone.0021149.g002
Table 3. Intention-to-treat effect of male circumcision estimated using BED incidence testing of blood samples obtained at the
last follow-up visit of the Orange Farm male circumcision trial.
Parameters
Cut-off 0.8 1.0 1.5 1.9
BED Incidence assay
window period (months)
6.5 8.1 12.1 15.4
Short-term specificity 0.87 0.87 0.87 0.87
Long-term specificity 0.96 0.94 0.91 0.89
Sensitivity 0.87 0.87 0.87 0.87
Shape of HIV incidence rate by age Constant Constant Constant Constant
Weights for tested recenta k1 k1 k1 k1
Weights for tested long-termb k2 k2 k2 k2
Results
Effect of the interventionc 0.42 0.36 0.34 0.37
95% CI 0.19–0.93 0.17–0.78 0.17–0.65 0.21–0.64
CI = confidence interval.
a bWeights k1 and k2 introduced in the Poisson log-linear model for each group
a among HIV-positive tested recent seroconverters and b among HIV-positive tested
long-term seroconverters.
cFactor by which the incidence rate is multiplied in the intervention group in comparison with the control group.
doi:10.1371/journal.pone.0021149.t003
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When we did not correct for misclassifications (i.e. k1 = 1 and
k2 = 0, or Se = r1 =r2 = 1), we obtained 0.53 (95%CI: 0.29–0.97),
0.49 (95%CI: 0.28–0.87), 0.49 (95%CI: 0.30–0.80) and 0.52
(95%CI: 0.35–0.80), which are also, and not surprisingly,
underestimations of the effect of the intervention with, however,
a statistically significant effect.
When we decreased the BED window period by 20%, the
impact of the intervention was reduced by 0.6% to 1.9%. When
we decreased the sensitivity by 20%, the impact of the intervention
was changed by 22.1% to 4.2%. When we decreased the short-
term specificity by 20%, the impact of the intervention was
changed by 227% to 35%. When we decreased the long-term
specificity by 20%, the impact of the intervention was increased
from 4.4% to 5.3%.
Discussion
Using theoretical analyses and mathematical simulations based
on realistic scenarios, we investigated the performance of the BED
incidence assay when used among young people recruited for a
cross-sectional survey from high HIV incidence rate areas of sub-
Saharan Africa. We were able to demonstrate that BED incidence
testing a) has the ability to measure with substantial precision the
effect of an HIV intervention aiming to reduce the HIV incidence
rate and b) can lead to a statistical power close to the power
obtained in classical cohort studies conducted among samples of
the same size as the cross sectional survey and in which HIV-
negative people are followed-up over a period of time equal to the
BED window period.
An illustration of the use of BED incidence testing to assess
the effect of an intervention was provided in another study
published by some of the co-authors [12]. The study
demonstrated that the protective effect of male circumcision
could have been calculated using only blood samples collected
from participants at the last follow-up visit of the Orange Farm
male circumcision trial. This was shown using BED window
periods ranging from six to 15 months, despite the presence at
baseline of HIV-positive individuals who were followed-up
exactly as HIV-negative participants. In the present study, the
baseline scenario was based on data from the Orange Farm
trial, and it demonstrated an adequate power and a precise
estimation of the intervention effect. This is the reason why it
was possible to replicate the results of the Orange Farm trial.
However, the present study has a wider scope and its findings
can be applied to various situations where the population
consists of young people among whom HIV is predominantly
transmitted heterosexually.
Our results are explained by the fact that in sub-Saharan
African settings with high HIV incidence rates and where
transmission is predominantly heterosexual, young people have
been exposed to HIV for a short duration because of their recent
onset of sexual activity. Hence, the use of the BED incidence assay
is optimized because the ratio of HIV incidence rate with HIV
prevalence is high. This high ratio leads to a lower absolute
number of individuals falsely identified as recent seroconverters, in
comparison with a population with a lower ratio, such as
populations with wider age ranges. Another interest in studying
young people is that the fraction of HIV-positive individuals on
antiretroviral drugs or having low CD4 counts is lower than
among older age cohorts because HIV infection is on average
more recent. It ensues that young HIV positive people are more
likely to be true recent seroconverters, hence the proportion of
corrections for misclassifications due to these factors are lower
[16,17].
We found that a Poisson log-linear model, which is a classical
multivariate statistical technique, can be used to analyze individual
data obtained with BED incidence testing, and estimate with
precision the effect of an intervention aiming to reduce HIV
incidence rates. Such estimation was obtained by correcting for
misclassifications, although it appears that a precise knowledge of
the characteristics of the BED HIV incidence assay (sensitivity,
specificities and window period) is not critical. This finding should
lead to a wider use of these assays in HIV prevention research
conducted among young people of sub-Saharan African settings
with high HIV incidence rates. Moreover, such method has the
ability to take into account cofactors of HIV incidence which can
be included in the Poisson log-linear model. These cofactors may
be collected among, or reported by, participants when a blood
sample is also obtained. As such, the heterogeneity among
participants can be accounted for, as long as it is not hidden. In
addition, it is also possible to take into account propensity score
weights. This allows to control for the selection bias due to a non-
randomized intervention, when the risk behaviour of intervention
and control group participants is likely dissimilar. The two
approaches can even be combined into the so-called double
robust estimation [18].
By searching the literature, we found only one study having
used classical statistical methods to analyze risk factors of recent
HIV infections identified with BED incidence testing [19].
However, to analyze risk factors of recent HIV infections is not
the same as to use BED incidence testing to estimate HIV IRR. As
shown in our study, correcting the BED incidence assay results to
calculate HIV IRR leads to a better estimation of the intervention
effect. Our study provides a theoretical framework for this type of
estimation.
Our calculations demonstrate that sample sizes needed to
estimate HIV IRR among young people and achieve an adequate
statistical power can remain reasonably small. This result should
change the assumption that HIV incidence assays are not practical
because they require very large samples. Large samples may be
needed to provide a precise estimation of HIV incidence rates
among the general population [20].
Our theoretical and practical calculations of the estimated
intervention effect, statistical power and confidence interval are
general, but make the main assumption that the HIV incidence
rate is constant as a function of time and age, as it is customary in
this type of study [21]. To obtain simplified formulae, it was also
assumed that the product of the HIV incidence rate by the
duration since age at sexual debut is relatively small (i.e. no more
than 0.35). These assumptions are acceptable when studying
people from a limited age range, for a limited period of time, and
with a recent onset of sexual activity. This is why our study
concentrated on young people, even though our results are more
general, as discussed in section A6 of the Text S1, where we
considered an age range with a inferior limit higher than the age at
onset of sexual activity.
Another interest in using incidence assays among young people
is the possibility to increase the assay window period by increasing
the cut-off value. For the BED assay, the conventional cut-off
value is 0.80. However a literature search showed that this value
has no real scientific basis. The possibility, when analyzing data
from young people, to use higher cut-off values of up to 1.89,
corresponding to a BED window period of about 15 months, has
already been demonstrated in a recent study [12] and is consistent
with theoretical studies showing that BED estimates can reflect an
HIV incidence rate more than two years in the past [17]. A
systematic review of the BED incidence assay [22] found that they
could produce accurate estimates of HIV incidence rates, but that
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they were very sensitive to methodological and parameter choices.
In particular, it was recommended that locally validated
calibration parameters be used to compute incidence rates and
correct for misclassifications [22]. Accordingly, our results were
obtained with numerical values for the BED window period, the
cut-off values, the specificities and the sensitivity yielded from a
study conducted in Orange Farm among young men [12].
However, the mathematical expressions of our findings are
general. Their use requires knowledge of the BED window period
to correct for misclassifications, as well as the sensitivity and the
specificities of the assay. These characteristics depend on the cut-
off value used as well as the setting where the data are obtained.
We compared results obtained during a classical cohort studies
with those obtained using the BED assay, with a window period
equal in duration to the duration of the cohort studies follow-up
period. However, cohort studies may have follow-up periods
lasting longer than the window period. To compensate, the size of
the cross-sectional survey during which BED incidence data is
collected would have to be increased.
Vaccine, microbicide, pre-exposure prophylaxis or other
potential HIV prevention or intervention studies would benefit
from precise comparison of short-term incidence rates through the
estimation of IRR using cross-sectional surveys. This requires that
not all participants receive the intervention, otherwise no
comparison will be possible and no IRR could be calculated.
Cross-sectional HIV IRR measures would reduce the need to
recruit longitudinal cohorts which are costly, and may suffer from
recruitment bias.
Estimating the effect of an intervention by assessing the IRR is
important in HIV prevention research. This effect may be more
difficult to assess using longitudinal cohorts than cross-sectional
studies. The current male circumcision roll-out study in Orange
Farm (ANRS-12126), in which free medicalised male circumcision
is made available to the community [23], was established to
evaluate the effect of male circumcision on the HIV incidence rate
in real life circumstances. The results of our study show that this
effect may well be assessed by conducting a post-intervention
cross-sectional survey. One additional advantage is that cross-
sectional respondents are more likely to be representative of the
population. Such characteristics are difficult to obtain when
recruiting a cohort. Another example is Project Accept (National
Institute of Mental Health, HPTN 043) [24], a community-based
randomized trial providing community mobilization, mobile HIV
voluntary counseling and testing, and comprehensive post-test
supportive services. Measuring baseline HIV prevalence among
the participating communities might have diluted the effect of the
intervention, therefore the trial outcomes will be assessed using
HIV incidence testing, and comparing IRR between control and
intervention communities.
In conclusion, BED incidence testing may be employed to assess
the effect of prevention interventions conducted among young
people using cross-sectional data.
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